Background: As a major source of morbidity and mortality, COVID-19 (coronavirus disease 2019) has developed. In both COVID-19 and other pneumonias, high T/I troponin levels may indicate damage to the heart. Objective: ln order to expand our understanding of COVID-19 cardiology effects, as well as provide insights into the features of people who are more prone to cardiovascular diseases. Methods: At isolation hospital in Zagazig, and the isolation hospital in Tripoli, Libya, 42 COVID-19 positive subjects were studied for their echocardiographic parameters, the study was carried out from March 5th, 2021, to September 4th 2021. Results: Arrhythmias, myocardial infarctions, valvular dysfunction, pulmonary hypertension, and right ventricular dysfunction (RVD) were found to have no statistically significant association to the severity of COVID-19. Mean of left ventricular ejection fraction (LVEF) was statistically lower among severe COVID-19 patients than moderate and mild cases but means of RV diameter (mm) was statistically higher among severe COVID-19 patients than moderate and mild cases, mean of fractional area change (FAC) was statistically lower in severe COVID-19 patients. Pulmonary hypertension was the second most common echocardiographic finding (38% of patients). There was no statistically significant difference in pulmonary hypertension across COVID-19 patients in relation to the severity (P=0.211).Conclusion: Echocardiography can provide us with important information which can help in managing of patients with COVID-19 while we must consider contamination risks as well as transmission of diseases
